Connect Biopharma Holdings (CNTB) EPS (Basic) (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted quarterly EPS (Basic) of -$0.34 for Q1 2026, down 84.86% year-on-year from -$2.27 in Q1 2025, and down 26.38% on a QoQ basis from -$0.27 in Q4 2025.
Connect Biopharma Holdings (CNTB) EPS (Basic) (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings (CNTB) has reported EPS (Basic) for 3 consecutive years, with -$0.34 the latest figure, recorded in Q1 2026.
- Quarterly EPS (Basic) fell 84.86% year-over-year to -$0.34 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.14 (down 267.54% YoY) and the FY2025 annual result came in at -$1.0, down 252.15% from the prior year.
- EPS (Basic) declined to -$0.34 in Q1 2026 per CNTB's latest filing, from -$0.27 in the prior quarter.
- Over the last five years, EPS (Basic) for CNTB reached as high as $0.27 in Q2 2024 and fell as low as -$0.34 in Q1 2026.
- A 3-year average of -$0.18 and a median of -$0.23 in 2025 frame the typical range for EPS (Basic).
- The largest YoY upside for EPS (Basic) was 17.63% in 2025 against a maximum downside of 186.39% in 2025.
- Year by year, EPS (Basic) stood at -$0.16 in 2024, then slumped by 68.29% to -$0.27 in 2025, then decreased by 26.38% to -$0.34 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.34, -$0.27, and -$0.31 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,933.35 Bn | 1,933.29 Bn | - | - |
| 3 | Akari Therapeutics | 1,063.56 Bn | 1,063.56 Bn | - | 0.00 |
| 4 | BeOne Medicines | 468.54 Bn | 463.75 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.20 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 63.57 Bn | 63.57 Bn | - | 0.00 |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 7.59 |
| 9 | Alnylam Pharmaceuticals | 37.75 Bn | 34.74 Bn | 959.66 Mn | 1.55 |
| 10 | Connect Biopharma Holdings | 120.44 Mn | 120.44 Mn | - | -0.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.34 |
| Dec 31, 2025 | -0.27 |
| Sep 30, 2025 | -0.31 |
| Jun 30, 2025 | -0.23 |
| Mar 31, 2025 | -0.19 |
| Dec 31, 2024 | -0.16 |
| Sep 30, 2024 | -0.23 |
| Jun 30, 2024 | 0.27 |
| Mar 31, 2024 | -0.16 |